Boston Scientific Corp
BSX76.270USD
-1.380-1.78%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
113.05B시가총액
38.96P/E TTM
자세한 내용은 Boston Scientific Corp 회사
Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.
Boston Scientific Corp 정보
종목 코드 BSX
회사 이름Boston Scientific Corp
상장일May 19, 1992
CEOMahoney (Michael F)
직원 수53000
유형Ordinary Share
회계 연도 종료May 19
주소300 Boston Scientific Way
도시MARLBOROUGH
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호01752-1234
전화15086834000
웹사이트https://www.bostonscientific.com/en-US/Home.html
종목 코드 BSX
상장일May 19, 1992
CEOMahoney (Michael F)
Boston Scientific Corp의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-58824.00%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+2081.00%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+2081.00%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+562.00%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+2084.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-12891.00%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+2081.00%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-2901.00%
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-58824.00%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+2081.00%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+2081.00%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+562.00%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+2084.00%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
24.13K
-12891.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Endoscopy
747.00M
14.75%
Peripheral Interventions
702.00M
13.86%
Urology
682.00M
13.46%
Electrophysiology
607.00M
11.98%
Watchman
470.00M
9.28%
기타
1.86B
36.66%
지역별USD
이름
수익
비율
United States
3.29B
65.03%
Asia Pacific
802.00M
15.83%
EMEA (Europe, Middle East and Africa)
793.00M
15.66%
Latin America and Canada
175.00M
3.46%
사업별
지역별
사업별USD
이름
수익
비율
Endoscopy
747.00M
14.75%
Peripheral Interventions
702.00M
13.86%
Urology
682.00M
13.46%
Electrophysiology
607.00M
11.98%
Watchman
470.00M
9.28%
기타
1.86B
36.66%
주식 보유 통계
마지막 업데이트: Sun, Feb 1
마지막 업데이트: Sun, Feb 1
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
9.37%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
기타
72.54%
주주
주주
비율
The Vanguard Group, Inc.
9.37%
Fidelity Management & Research Company LLC
6.11%
BlackRock Institutional Trust Company, N.A.
5.37%
State Street Investment Management (US)
4.38%
PRIMECAP Management Company
2.23%
기타
72.54%
주주 유형
주주
비율
Investment Advisor
51.52%
Investment Advisor/Hedge Fund
29.11%
Hedge Fund
4.91%
Pension Fund
2.90%
Research Firm
2.71%
Bank and Trust
1.98%
Sovereign Wealth Fund
1.58%
Family Office
0.29%
Private Equity
0.19%
기타
4.82%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
2858
1.40B
94.34%
-402.85K
2025Q3
2905
1.40B
94.56%
+9.92M
2025Q2
2818
1.39B
94.08%
+7.87M
2025Q1
2724
1.38B
93.98%
-8.23M
2024Q4
2559
1.38B
93.68%
+12.79M
2024Q3
2401
1.36B
94.13%
-3.01M
2024Q2
2325
1.37B
94.20%
+2.64M
2024Q1
2212
1.37B
95.15%
-32.63M
2023Q4
2153
1.38B
96.34%
-8.17M
2023Q3
2083
1.39B
95.41%
+17.41M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
137.57M
9.28%
+1.09M
+0.80%
Sep 30, 2025
Fidelity Management & Research Company LLC
90.62M
6.11%
-8.85M
-8.90%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
79.60M
5.37%
+1.41M
+1.81%
Sep 30, 2025
State Street Investment Management (US)
64.93M
4.38%
-266.30K
-0.41%
Sep 30, 2025
PRIMECAP Management Company
33.10M
2.23%
-1.56M
-4.50%
Sep 30, 2025
Geode Capital Management, L.L.C.
32.69M
2.21%
+265.55K
+0.82%
Sep 30, 2025
Capital World Investors
26.65M
1.8%
-1.88M
-6.58%
Sep 30, 2025
Managed Account Advisors LLC
23.16M
1.56%
+1.11M
+5.03%
Sep 30, 2025
The Bollard Group, LLC
19.73M
1.33%
-345.87K
-1.72%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
19.46M
1.31%
-275.11K
-1.39%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Mon, Dec 1
마지막 업데이트: Mon, Dec 1
이름
비율
iShares U.S. Medical Devices ETF
12.15%
Goldman Sachs Future Health Care Equity ETF
8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
3.87%
Tema Heart & Health ETF
3.66%
First Trust Bloomberg R&D Leaders ETF
3.14%
Parnassus Core Select ETF
3.1%
WisdomTree US AI Enhanced Value Fund
3.1%
Health Care Select Sector SPDR Fund
3.06%
Global X Aging Population ETF
2.99%
Proshares Ultra Health Care
2.95%
더 보기
iShares U.S. Medical Devices ETF
비율12.15%
Goldman Sachs Future Health Care Equity ETF
비율8.33%
Invesco Dorsey Wright Healthcare Momentum ETF
비율3.87%
Tema Heart & Health ETF
비율3.66%
First Trust Bloomberg R&D Leaders ETF
비율3.14%
Parnassus Core Select ETF
비율3.1%
WisdomTree US AI Enhanced Value Fund
비율3.1%
Health Care Select Sector SPDR Fund
비율3.06%
Global X Aging Population ETF
비율2.99%
Proshares Ultra Health Care
비율2.95%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
